-
2022-502732-39-00
10
2023-09-01
Previously treated non-ocular advanced melanoma
-
2022-500933-10-00
11
2023-08-02
Preeclampsia during pregnancy
-
2022-501822-39-00
9
2023-07-31
Glioblastoma
-
2024-519156-93-00
4
2023-07-21
Invasive mechanical ventilation expected to be required for more than
-
2024-513652-15-00
7
2023-07-19
Severe Combined Immuno-Deficiency (SCID) caused by biallelic mutations
-
2022-500587-35-01
5
2023-07-06
Stroke
-
2022-500967-11-00
5
2023-07-06
Previously Untreated Metastatic or Unresectable Melanoma
-
2022-502202-33-00
4
2023-07-06
Achondroplasia in Children and Adolescents
-
2024-512999-35-00
4
2023-06-23
Patients with HER 2 negative locally advanced, recurrent or metastatic
-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2022-502229-16-00
5
2023-06-19
Ventilator acquired pneumonia
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2024-517953-28-00
7
2023-06-07
Treatment in haematopoietic stem cell transplantation
-
2022-501344-14-00
5
2023-06-05
Paediatric Patients with Severe Eosinophilic Asthma
Asthma is a long-t
-
2022-500230-28-00
4
2023-06-02
Highly sensitised paediatric patients with a positive crossmatch again
-
2024-512231-72-00
1
2023-05-31
Non-ischemic Dilated Cardiomyopathies
-
2024-513312-95-00
7
2023-05-30
Part B+C. Primary central nervous system lymphoma (PCNSL)
-
2023-504263-16-00
5
2023-05-25
This is an extension study designed to provide continued treatment for
-
2022-501688-42-00
5
2023-05-24
Low Grade Glioma
-
2024-513669-38-00
5
2023-05-17
Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
-
2024-512878-98-00
9
2023-05-16
Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative
Breas
-
2024-515146-16-00
5
2023-05-15
Colorectal surgery
-
2024-511936-28-00
1
2023-05-12
Relapsed/refractory hematological malignancies
or advanced/metastatic
-
2023-504861-22-00
4
2023-05-05
Pulmonary arterial hypertension